Congratulations to Dr. Sam Lai, and the U.S. Rectal Cancer Research Group for their report on 545 patients managed with a watch and wait approach. Our group is recruiting more U.S. centers to collaborate. Join us! Jon.vogel@cuanschutz.edu
Congrats to our 108 team members who graduated from @GuildEducation-supported programs in the last year! In our first year offering this tuition-free education benefit, thousands of team members have signed up. We can't wait to see how many graduates we celebrate next year!
Laparoscopic TAP block with ropivicaine, decadron, and precedex significantly reduces opioid consumption following colorectal surgery #ASCRS22@SamuelHLai@CUDeptSurg@cugites
Adjuvant chemotherapy improves survival in patients with rectal cancer undergoing chemoradiation and TME even in presence of pCR. Excellent presentation by @SamuelHLai University of Colorado @CUDeptSurg@cugites@BrandonCChapman at #ASCRS22
Following suit with another BEST OF RECTAL CANCER plenary talk, Sam Lai (@SamuelHLai) presenting on the survival benefit of adjuvant chemotherapy after pCR following neoadjuvant long course chemorads in stage II/III rectal cancer #ASCRS22@CUDeptSurg@BrandonCChapman